|
1
|
Dobson R and Giovannoni G: Multiple
sclerosis-a review. Eur J Neurol. 26:27–40. 2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tarlinton RE, Khaibullin T, Granatov E,
Martynova E, Rizvanov A and Khaiboullina S: The interaction between
viral and environmental risk factors in the pathogenesis of
multiple sclerosis. Int J Mol Sci. 20(303)2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Arneth B: Multiple sclerosis and smoking.
Am J Med. 133:783–788. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Pytel V, Matías-Guiu JA, Torre-Fuentes L,
Montero-Escribano P, Maietta P, Botet J, Álvarez S, Gómez-Pinedo U
and Matías-Guiu J: Exonic variants of genes related to the vitamin
D signaling pathway in the families of familial multiple sclerosis
using whole-exome next generation sequencing. Brain Behav.
9(e01272)2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kim Y and Connor JR: The roles of iron and
HFE genotype in neurological diseases. Mol Aspects Med.
75(100867)2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Grubić Kezele T and Ćurko-Cofek B:
Age-related changes and sex-related differences in brain iron
metabolism. Nutrients. 12(2601)2020.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zecca L, Youdim MB, Riederer P, Connor JR
and Crichton RR: Iron, brain ageing and neurodegenerative
disorders. Nat Rev Neurosci. 5:863–873. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Zivadinov R, Heininen-Brown M, Schirda CV,
Poloni GU, Bergsland N, Magnano CR, Durfee J, Kennedy C, Carl E,
Hagemeier J, et al: Abnormal subcortical deep-gray matter
susceptibility-weighted imaging filtered phase measurements in
patients with multiple sclerosis: A case-control study. Neuroimage.
59:331–339. 2012.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hagemeier J, Weinstock-Guttman B,
Heininen-Brown M, Poloni GU, Bergsland N, Schirda C, Magnano CR,
Kennedy C, Carl E, Dwyer MG, et al: Gray matter SWI-filtered phase
and atrophy are linked to disability in MS. Front Biosci (Elite
Ed). 5:525–532. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Zivadinov R, Tavazzi E, Bergsland N,
Hagemeier J, Lin F, Dwyer MG, Carl E, Kolb C, Hojnacki D, Ramasamy
D, et al: Brain iron at quantitative MRI is associated with
disability in multiple sclerosis. Radiology. 289:487–496.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Bergsland N, Tavazzi E, Schweser F,
Jakimovski D, Hagemeier J, Dwyer MG and Zivadinov R: Targeting iron
dyshomeostasis for treatment of neurodegenerative disorders. CNS
Drugs. 33:1073–1086. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Bergsland N, Agostini S, Laganà MM,
Mancuso R, Mendozzi L, Tavazzi E, Cecconi P, Clerici M and Baglio
F: Serum iron concentration is associated with subcortical deep
gray matter iron levels in multiple sclerosis patients.
Neuroreport. 28:645–648. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ćurko-Cofek B, Kezele TG, Marinić J, Tota
M, Čizmarević NS, Milin Č, Ristić S, Radošević-Stašić B and
Barac-Latas V: Chronic iron overload induces gender-dependent
changes in iron homeostasis, lipid peroxidation and clinical course
of experimental autoimmune encephalomyelitis. Neurotoxicology.
57:1–12. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Feder JN, Gnirke A, Thomas W, Tsuchihashi
Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan
A, et al: A novel MHC class I-like gene is mutated in patients with
hereditary haemochromatosis. Nat Genet. 13:399–408. 1996.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Faraj SA and Al-Abedy NM: Serum hepcidin
hormone level and its genes polymorphism, Genetic Variation,
Trindade Maia R and de Araújo Campos M (eds). IntechOpen, 2021.
doi: 10.5772/intechopen.93622. Available from: https://www.intechopen.com/chapters/73214.
|
|
16
|
Barton JC, Edwards CQ and Acton RT: HFE
gene: Structure, function, mutations, and associated iron
abnormalities. Gene. 574:179–192. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Hollerer I, Bachmann A and Muckenthaler
MU: Pathophysiological consequences and benefits of HFE mutations:
20 Years of research. Haematologica. 102:809–817. 2017.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Adams PC, Reboussin DM, Barton JC, McLaren
CE, Eckfeldt JH, McLaren GD, Dawkins FW, Acton RT, Harris EL,
Gordeuk VR, et al: Hemochromatosis and iron-overload screening in a
racially diverse population. N Engl J Med. 352:1769–1778.
2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Fleming RE and Sly WS: Mechanisms of iron
accumulation in hereditary hemochromatosis. Annu Rev Physiol.
64:663–680. 2002.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Bahram S, Gilfillan S, Kühn LC, Moret R,
Schulze JB, Lebeau A and Schümann K: Experimental hemochromatosis
due to MHC class I HFE deficiency: Immune status and iron
metabolism. Proc Natl Acad Sci USA. 96:13312–13317. 1999.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Rubio JP, Bahlo M, Tubridy N, Stankovich
J, Burfoot R, Butzkueven H, Chapman C, Johnson L, Marriott M, Mraz
G, et al: Extended haplotype analysis in the HLA complex reveals an
increased frequency of the HFE-C282Y mutation in individuals with
multiple sclerosis. Hum Genet. 114:573–580. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ristić S, Lovrecić L, Brajenović-Milić B,
Starcević-Cizmarević N, Jazbec SS, Sepcić J, Kapović M and Peterlin
B: Mutations in the hemochromatosis gene (HFE) and multiple
sclerosis. Neurosci Lett. 383:301–304. 2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Kotze MJ, de Villiers JN, Warnich L,
Schmidt S, Carr J, Mansvelt E, Fourie E and van Rensburg SJ: Lack
of clinical manifestation of hereditary haemochromatosis in South
African patients with multiple sclerosis. Metab Brain Dis.
21:109–120. 2006.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ramagopalan SV, Cukjati M, Cernilec M,
DeLuca GC, Dyment DA, Degenhardt A, Sadovnick AD, Serbec VC, Ebers
GC and Duquette P: Mutations in the hemochromatosis gene and the
clinical outcome of multiple sclerosis. J Neuroimmunol.
203:104–107. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Bettencourt A, Silva AM, Santos E, Gomes
S, Mendonça D, Costa PP, Faustino P and Silva BM: HFE gene
polymorphisms and severity in Portuguese patients with multiple
sclerosis. Eur J Neurol. 18:663–666. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Gemmati D, Zeri G, Orioli E, De Gaetano
FE, Salvi F, Bartolomei I, D'Alfonso S, Dall'osso C, Leone MA,
Singh AV, et al: Polymorphisms in the genes coding for iron binding
and transporting proteins are associated with disability, severity,
and early progression in multiple sclerosis. BMC Med Genet.
13(70)2012.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Hagemeier J, Ramanathan M, Schweser F,
Dwyer MG, Lin F, Bergsland N, Weinstock-Guttman B and Zivadinov R:
Iron-related gene variants and brain iron in multiple sclerosis and
healthy individuals. Neuroimage Clin. 17:530–540. 2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View
Article : Google Scholar
|
|
29
|
Girouard J, Giguère Y, Delage R and
Rousseau F: Prevalence of HFE gene C282Y and H63D mutations in a
French-Canadian population of neonates and in referred patients.
Hum Mol Genet. 11:185–189. 2002.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Sadovnick AD: Genetic background of
multiple sclerosis. Autoimmun Rev. 11:163–166. 2012.PubMed/NCBI View Article : Google Scholar
|
